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Abstract Spermadhesin PSP-II was isolated from the non-hep- 
arin-binding fraction of boar seminal plasma; its disulphide bridge 
pattern, and the location of a single N-glycosylation site were 
established. PSP-II forms a heterodimer with specific N-gly- 
coforms of PSP-I. Although both subunits possess heparin-bind- 
ing capability, the PSP-I/PSP-II complex does not. The hetero- 
dimer contains binding sites for zona pellucida glycoproteins and 
soybean trypsin inhibitor located in the PSP-II subunit. However, 
the PSP-IfPSP-II heterodimer binds only loosely to the sperm 
surface and is easily removed during in vitro capacitation, sug- 
gesting that the zona pellucida binding activity may not be rele- 
vant for gamete interaction. Our results show that dimerization 
of spermadhesins PSP-I and PSP-II markedly affects their bind- 
ing capabilities. 
Key words: Boar spermadhesin; Seminal plasma protein; 
Zona pellucida binding protein; Glycosylation; 
Soybean trypsin inhibitor binding protein 
1. Introduction 
The initial step of fertilization involves interaction of sperm 
surface lectins with oligosaccharides of the oocyte's zona pellu- 
cida [1]. Boar spermadhesins are a family of carbohydrate- 
binding proteins with molecular masses between 12-16 kDa. 
Spermadhesins AQN-1, PSP-I, PSP-II, AQN-3, and AWN 
(isoforms 1 and 2) are major secretory products of the seminal 
vesicle epithelium, accounting for over 80% of the total seminal 
fluid proteins [2,3]. AWN-1 is, in addition, synthesized by tu- 
buli recti and rete testis epithelial cells [4]. Boar spermadhesins 
coat the acrosomal cap of spermatozoa [2], and are thought o 
play a role in porcine sperm capacitation and gamete recogni- 
tion and binding [5]. 
The amino acid sequences of five boar spermadhesins have 
been determined: AQN-1 [6], PSP-I (AQN-2) [7,8], PSP-II [9], 
AQN-3 [10], and AWN (1 and 2) [11]. AWN-1 and AWN-2 
differ only in that the latter contains an acetylated N-terminal 
residue. N-glycoforms of AQN-3 [7] and N- and O-glycosylated 
AWN species [12,13] have also been identified. Glycosylation 
not only contributes to the structural diversity of the protein 
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family but also affects the ligand-binding capabilities of the 
glycosylated spermadhesins, i.e. it abolishes their zona pellu- 
cida-binding activity without impairing heparin binding 
[8,12,131. 
AQN-1, AQN-2, AQN-3, and AWN are heparin-binding 
spermadhesins [14]. Here, we show that PSP-II is a major com- 
ponent of the non-heparin-binding fraction of boar seminal 
plasma. We have determined the location of disulphide bridges 
and its single N-glycosylation site. In addition, we show that 
PSP-II exist as a heterodimer with glycoforms of PSP-I, and 
report the effect of dimerization on the ligand-binding capabil- 
ities of the isolated subunits. 
2. Materials and methods 
Freshly ejaculated boar sperm was collected with an artificial vagina. 
Spermatozoa and seminal plasma were separated by centrifugation at 
12,000 xg for 15 min. Seminal plasma was fractionated by affinity 
chromatography on heparin-Sepharose as described [14]. The non- 
heparin-binding fraction was dialyzed against distilled water, lyophil- 
ized, and the proteins purified by reverse-phase HPLC on a Lichrocart 
(Merck) preparative (250 x 10 mm, 10/tm particle size) column eluted 
at 3 ml/min with a mixture of 0.1% trifluoroacetic acid in water (A) and 
acetonitrile (B), isocratically (25% B) for 5 min, followed by 2545% 
B for 5 min, 45-60% B for 15 min, and 60-70% B for 5 min. 
Determination f the apparent molecular masses of the proteins of 
the non-heparin-binding fraction, or of reverse-phase HPLC-purified 
protein, were estimated by gel-filtration chromatography on either a 
2,000 × 5 cm Sephadex G-50 column or a Superose-12 (Pharmacia) 
column in 50 mM Tris-HCl, 150 mM NaCI, 1 mM EDTA, 0.025% 
sodium azide, pH 7.4. For calibration, a mixture of dextran blue 2000, 
bovine serum albumin (67 kDa), ovalbumin (43 kDa), ribonuclease A 
(14 kDa), and cyanocobalamine w re used as molecular mass 
standards. 
The ability of purified proteins to bind biotinylated ligands (soybean 
trypsin inhibitor, heparin, and zona pellucida glycoproteins) was deter- 
mined by ELISA [8]. 
SDS-polyacrylamide g l electrophoresis was done according to 
Laemmli [15]. 
Amino acid analyses were done with a Pharmacia Alpha Plus ana- 
lyzer after sample hydrolysis with 6 N HC1 at 110°C for 24 h. For amino 
sugar and neutral sugar analyses, the samples were hydrolyzed with 4 N 
HC1 for 4 h or 2 N HC1 for 2 h, respectively, at110°C. For sialic acid 
determination, the samples were hydrolyzed with 0.2 N trifluoroacetic 
acid for 1 h at 80°C. After drying the hydrolyzates in a SpeedVac, the 
monosaccharides were resolved on a CarboPac PAl column (4 x 250 
mm) eluting at 1 ml/min isocratically with either 16 mM NaOH (for 
amino and neutral sugars) or with 20 mM NaOH in 60 mM sodium 
acetate (for sialic acid), and analyzed using a Dionex DX-300 analyzer 
equipped with pulsed amperometric detector and the AI-450 chroma- 
tography software [14]. 
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Purified PSP-II (10 mg/ml in 70% (v/v) formic acid) was degraded 
with cyanogen bromide (100 mg/ml final concentration) overnight at 
room temperature in Nz-flushed tubes in the dark. Enzymatic digestions 
of purified proteins or fragments (~5 mg/ml in 100 mM Tris-HC1, 150 
mM NaCI, 1 M guanidine hydrochloride, pH 8.0) were performed with 
chymotrypsin, trypsin (Sigma) or endoproteinase Lys-C (Boehringer 
Mannheim) overnight at 37°C with an enzyme: substrate ratio of 1 : 100 
(w/w). CNBr- and proteolytic fragments were isolated by reverse-phase 
HPLC on a Lichrospher RP-100 C18 column (250 x 4 mm, 5pm parti- 
cle size) (Merck) using the same chromatographic systems as above. 
N-terminal sequence analyses were done with Applied Biosystems 
sequencers 473A and Procise following the manufacturer's in tructions. 
Deglycosylation f isolated proteins with PNGaseF was done as in 
[8]. 
The molecular masses of proteins were determined by matrix-assisted 
laser desorption ionization time-of-flight mass spectrometry using a 
fOCUS LD-TOF (GSG, Karlsruhe) mass spectrometer and ~-cyano-4- 
hydroxycinamic a id as matrix. The molecular masses of peptides were 
measured by either electrospray ionization mass spectrometry using ac 
Sciex API-III LC/MS/MS triple quadropole instrument, orby fast atom 
bombardment liquid secondary-ion ionization using a MAT 900 mass 
spectrometer. 
3. Results and discussion 
3.1. Isolation and structural characterization of  non-heparin- 
binding boar seminal plasma proteins 
Boar seminal plasma was fractionated by affinity chromatog- 
raphy on a heparin-Sepharose column [14] and the proteins in 
the flow-through fraction were purified by reverse-phase HPLC 
(Fig. 1). SDS-polyacrylamide g l electrophoretic analysis of the 
chromatographic peaks showed that both of them contained 
heterogeneous material with apparent molecular masses of 16- 
18 kDa (Fig. 1, inset, lanes a and c). However, in each case, a 
single N-terminal amino acid sequence was obtained. Further- 
more, both proteins are N-glycosylated (Table 1) and treatment 
of the isolated protein fractions with PNGaseF yielded a single 
electrophoretic band (Fig. 1, inset, lanes b and d), indicating 
that the proteins of each peak are glycoforms. 
The N-terminal amino acid sequences of the isolated proteins 
we re: 
LDYHAXGGRLTDDYGTIFTYKGPKTE (peak 1) and 
AR INGPDEXGRVIKDTSGSISNTDRQKNLXTWTILMK-  
PDQKVRMAIPY (peak 2). 
In some preparations, peak 2 contained a mixture of two 
N-terminal sequences (ARINGPDE.. .  and RINGPDE...),  indi- 
cating that partial N-terminal degradation may occur. 
The N-terminal sequences of the proteins in peaks 1 and 2 
are identical with those of PSP-I and PSP-II, respectively [7-9], 
except for position 8 of PSP-II where glutamic acid was found 
Table 1 
Carbohydrate content of PSP-1 and PSP-II isolated from the non- 
heparin-binding fraction of boar seminal plasma by reverse-phase 
HPLC as shown in Fig. 1 
Monosaccharide PSP-I PSP-II 
(mol/mol protein) 
Fucose 0.6 0.3 
Galactose 1.5 1.2 
Manose 2.5 2.2 
Glucosamine 3.7 3.9 
Galactosamine 0.4 0.6 
N-acetyl neuraminic acid 1.1 1.4 
~0.8  
7o "7" 
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Fig. I. Isolation by reverse-phase HPLC of the proteins of the non- 
heparin-binding fraction of boar seminal plasma. Inset: SDS-(15%) 
polyacrylamide g l electrophoresis of the intact proteins recovered in 
peaks 1 (lane a) and 2 (lane c). Lanes b and d show the same proteins 
as in lanes a and c, respectively, after deglycosylation with PNGaseF. 
Lane s, molecular mass standards, from top to bottom: phosphorylase 
b, bovine serum albumin, ovalbumin, carbonic anhydrase, soybean 
trypsin inhibitor, and lysozyme, whose molecular masses are indicated 
at the left. 
in the protein ([7] and this work) but glutamine has been re- 
ported in a PSP-II cDNA [9]. 
The identity of the amino acid sequence of the protein of 
peak 1 with that of PSP-I was further verified by reverse-phase 
chymotryptic peptide mapping and characterization f the pro- 
teolytic fragments by amino acid and mass spectrometric anal- 
yses (not shown). In addition, the location of the two disulphide 
bridges (between cysteine residues 6-27 and 50-71) and the 
glycosylation site at asparagine 47 [8] were conserved. Further- 
more, the molecular mass of PSP-1 deglycosylated with PN- 
GaseF, determined by mass spectrometry, was 11,982 + 4 Da, 
which is close to the average molecular mass of PSP-I calcu- 
lated from its amino acid sequence (11,979.7 Da) [7,8]. 
The amino acid sequence of PSP-II was established by com- 
bination of N-terminal sequence analysis and characterization 
of overlapping chymotryptic, tryptic, endoproteinase Lys-C, 
and cyanogen bromide-derived peptides. Except at position 8 
(see above) our sequence is identical to a sequence obtained by 
cDNA technology (9) (Fig. 2). Analysis of proteolytic frag- 
ments of PSP-II showed that peak T-11 (M + H ÷ -- 1,579.8 Da) 
contained two tryptic peptides: 49LNLAXGK55 and 
73LXAGAAIVF81 connected by a single disulphide bridge be- 
tween cysteines 53 and 74. A second disulphide bond was lo- 
cated in a cyanogen bromide fragment corresponding to resi- 
dues 1-36. This fragment (M + H ÷ = 3,988.6 + 3.8 Da) did not 
contain free cysteines but two ethylpyridylcysteine residues/mol 
peptide were quantitated by amino acid analysis following re- 
duction and treatment with 4-vinylpyridine. Furthermore, the 
molecular mass of the derivatized peptide was 4,201 + 3.1 Da. 
These data clearly showed that cysteines 9 and 30 form a di- 
sulphide bridge. The two disulphide bridges of PSP-II are con- 
served in all other members of the boar spermadhesin family 
(Fig. 2). In addition, the same cystine pattern has been reported 
in aSFP, a bovine seminal plasma polypeptide which is struc- 
turally related to boar spermadhesins [17]. This feature may be 
important for maintaining the correct hree-dimensional struc- 
ture of spermadhesins. Other conserved characteristics in the 
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Fig. 2. Alignment of the amino acid sequences of spermadhesins. Positions with absolutely conserved residues ( ) and conservative substitutions (,) 
in all polypeptides are shown N 5°, asparagine r sidues which are constitutively glycosylated in PSP-I (8) and in glycoforms of AQN-3 (8) and 
AWN (12,13); N98, glycosylated asparagine inPSP-II (this work); S 52 and T 95, serine and threonine residues which are O-glycosylated in glycoforms 
of AWN (13). 
porcine and bovine proteins, which may define a consensus 
sequence pattern, are summarized in Fig. 2. 
Amino acid and carbohydrate analyses of proteolytic frag- 
ments revealed that PSP-II possessed a single N-glycosylation 
site at asparagine 98. Mass spectrometric analysis of the PSP-II 
glycoform yielded a broad peak between 14,300 and 15,000 Da, 
whereas the average molecular mass measured for PNGaseF- 
deglycosylated PSP-II was 12,410 + 8 Da. This mass is slightly 
lower than that calculated for the complete PSP-II sequence 
(116 residues, 12,643.5 Da) and may correspond to a truncated 
form of PSP-II (residues 2-115, calculated molecular mass: 
12,409.4). C-terminal degradation of glycosylated forms of 
AWN-1 following treatment with PNGaseF has been reported 
previously [12]. 
3.2. PSP-H forms a heterodimer with specific glycoforms of 
PSP-I 
To determine the aggregation state of the non-heparin-bind- 
ing proteins of boar seminal plasma, the heparin-Sepharose 
flow-through fraction was chromatographed on either an 
FPLC Superose-12 ora Sephadex G-50 column. In both cases, 
a single symmetrical peak eluting with an approximate appar- 
ent molecular mass of 32 kDa was obtained, (Fig. 3). Reverse- 
phase HPLC analysis of fractions along this peak (labeled 'o' 
in Fig. 3) and quantitation of isolated PSP-I and PSP-II by 
amino acid analysis revealed that the glycoproteins were pres- 
ent in equimolar amounts. On the other hand, isolated PSP-I 
and PSP-II eluted from the size-exclusion columns as monom- 
eric (16-18 kDa) proteins (Fig. 3, - • .). Similar esults have been 
Table 2 
Ligand binding capabilities of the PSP-I/PSP-II complex and its iso- 
lated subunits, as determined using a solid-phase assay and biotinylated 
ligands 
Ligand PSP-I/PSP-II PSP-I PSP-II 
Heparin + + 
Soybean trypsin inhibitor + - + 
Zona pellucida glycoproteins + + 
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Fig. 3. Fractionation fthe non-heparin-binding fraction of boar sem- 
inal plasma by gel filtration on Sephadex G-50. The elution position of 
molecular mass tandards is indicated at the top: DB, dextran blue 2000 
(< 2,000 kDa); BSA, bovine serum albumin (67 kDa); OVA, ovalbumin 
(43 kDa); RIB, ribonuclease A (14 kDa); COB, cyanocobalamine (1,350 
Da). The symbol 'o' along the PSP-I/PSP-II peak (...) indicates the 
elution position of samples which were analyzed by reverse-phase 
HPLC (as in Fig. 1) followed by quantitation of isolated PSP-I and 
PSP-II by amino acid analysis. The discontinous line shows the eluting 
position of isolated PSP-I and PSP-II. 
reported using ion-exchange and gel-filtration chromatography 
[7]. This strongly suggests that both components of the non- 
heparin-binding fraction of boar seminal plasma exist as heter- 
odimers. 
PSP-I has also been isolated from the heparin-binding frac- 
tion of boar seminal plasma [8]. Although heparin-binding and 
non-heparin-binding PSP-I molecules have identical amino 
acid sequences and location of posttranslational modifications 
(see above), they are differently glycosylated. Thus, although 
both heparin-binding and non-heparin-binding PSP-| gly- 
coforms, contain a single N-linked carbohydrate, notably the 
latter (Table l) but not the former [8] contains galactosamine, 
galactose and sialic acid. Thus, it appears that the type of 
glycosylation may determine which PSP-I glycoforms are re- 
cruited by PSP-II to form heterodimers. 
3.3. Effect of  dimerization on the Iigand binding capabilities of 
isolated PSP-I and PSP-H 
The ability of the PSP-I/PSP-II heterodimer and its isolated 
subunits to bind known ligands of other boar spermadhesins, 
i.e. soybean trypsin inhibitor (STI), heparin, and zona pellucida 
glycoproteins (ZPG) [5], was assessed using a solid-phase 
(ELISA) assay and biotinylated ligands. It was found (Table 2) 
that, although the heterodimer did not bind heparin, both sub- 
units possessed this binding activity. In addition, the PSP-I/ 
PSP-II complex and isolated PSP-II, but not PSP-I, showed 
affinity for soybean trypsin inhibitor and zona pellucida 
glycoproteins. These results indicate that the binding site(s) for 
STI and ZPG on PSP-I/PSP-II are located on PSP-II, and that 
dimerization impairs the heparin-binding capability of both 
subunits. Whether dimerization sterically blocks the heparin 
binding site(s), or affects the conformation of the heparin- 
binding regions remains unclear. On the other hand, glycosyla- 
tion at asparagine 47 is the cause of the inability of PSP-I to 
bind STI and ZPG [5,8]. 
The zona pellucida glycoprotein-binding activity of PSP-I/ 
PSP-II would suggest a role during gamete interaction. How- 
ever, PSP-I/PSP-II have been found to bind only loosely to the 
sperm surface, and is absent from in vitro capacitated sperma- 
tozoa [2]. Interestingly, heparin-binding PSP-I molecules are 
present on capacitated sperm, suggesting that either the type of 
glycosylation or complex formation with PSP-II also influences 
the sperm coating characteristics of PSP-I (and/or PSP-II) gly- 
coforms. Thus, although the biological function(s) of boar sem- 
inal plasma PSP-I/PSP-II remain obscure, our results how that 
heterodimerization of specific glycoforms of PSP-I with PSP-II 
exerts a profound effect on the ligand-binding characteristics 
and compartmentalization of these boar spermadhesins. 
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